SANARE BIOSCIENCE

Sanare Bioscience specializes in the development and commercialization of medical products that improve patient outcomes. Its flagship product is a patent-pending treatment for marijuana overdose. Tetrahydrocannabinol (THC), the main psychoactive component of the cannabis plant, in large doses can be toxic and can cause dangerous psychological and physiological side effects. Sanare's product neutralizes THC toxicity within the blood stream, which sobers up the patient and eliminates side effects. As a result, patients can be discharged from ER early or avoid hospitalizations in the first place, thereby saving hospitals treatment costs.